BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30479356)

  • 21. Epigenetic differences at the HTR2A locus in progressive multiple sclerosis patients.
    Maltby VE; Lea RA; Burnard S; Xavier A; Van Cao T; White N; Kennedy D; Groen K; Sanders KA; Seeto R; Bray S; Gresle M; Laverick L; Butzkueven H; Scott RJ; Lechner-Scott J
    Sci Rep; 2020 Dec; 10(1):22217. PubMed ID: 33335118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global DNA methylation changes in treated and untreated MS patients measured over time.
    Brorson IS; Eriksson AM; Høgestøl E; Leikfoss IS; Harbo HF; Berge T; Vitelli V; Bos SD
    J Neuroimmunol; 2022 Mar; 364():577808. PubMed ID: 35093762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic aspects of multiple sclerosis and future therapeutic options.
    Jamebozorgi K; Rostami D; Pormasoumi H; Taghizadeh E; Barreto GE; Sahebkar A
    Int J Neurosci; 2021 Jan; 131(1):56-64. PubMed ID: 32075477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-wide DNA methylation profiling of CD8+ T cells shows a distinct epigenetic signature to CD4+ T cells in multiple sclerosis patients.
    Maltby VE; Graves MC; Lea RA; Benton MC; Sanders KA; Tajouri L; Scott RJ; Lechner-Scott J
    Clin Epigenetics; 2015; 7():118. PubMed ID: 26550040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct Epigenetic Effects of Tobacco Smoking in Whole Blood and among Leukocyte Subtypes.
    Su D; Wang X; Campbell MR; Porter DK; Pittman GS; Bennett BD; Wan M; Englert NA; Crowl CL; Gimple RN; Adamski KN; Huang Z; Murphy SK; Bell DA
    PLoS One; 2016; 11(12):e0166486. PubMed ID: 27935972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel microRNA-132-sirtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis [corrected].
    Miyazaki Y; Li R; Rezk A; Misirliyan H; Moore C; Farooqi N; Solis M; Goiry LG; de Faria Junior O; Dang VD; Colman D; Dhaunchak AS; Antel J; Gommerman J; Prat A; Fillatreau S; Bar-Or A; ;
    PLoS One; 2014; 9(8):e105421. PubMed ID: 25136908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Minimally-invasive Blood-derived Biomarker of Oligodendrocyte Cell-loss in Multiple Sclerosis.
    Olsen JA; Kenna LA; Tipon RC; Spelios MG; Stecker MM; Akirav EM
    EBioMedicine; 2016 Aug; 10():227-35. PubMed ID: 27381476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic changes in patients with multiple sclerosis.
    Koch MW; Metz LM; Kovalchuk O
    Nat Rev Neurol; 2013 Jan; 9(1):35-43. PubMed ID: 23165337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide DNA methylation profiling in chronic lymphocytic leukaemia.
    Zhang Q; Gao Y; Lin S; Goldin LR; Wang Y; Stevenson H; Edelman DC; Killian K; Marti G; Meltzer PS; Xiang S; Caporaso NE
    Front Genet; 2022; 13():1056043. PubMed ID: 36712882
    [No Abstract]   [Full Text] [Related]  

  • 30. Epigenome-wide association study of Alzheimer's disease replicates 22 differentially methylated positions and 30 differentially methylated regions.
    Li QS; Sun Y; Wang T
    Clin Epigenetics; 2020 Oct; 12(1):149. PubMed ID: 33069246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ZNF718, HOXA4, and ZFP57 are differentially methylated in periodontitis in comparison with periodontal health: Epigenome-wide DNA methylation pilot study.
    Hernández HG; Hernández-Castañeda AA; Pieschacón MP; Arboleda H
    J Periodontal Res; 2021 Aug; 56(4):710-725. PubMed ID: 33660869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinoic acid enhances the levels of IL-10 in TLR-stimulated B cells from patients with relapsing-remitting multiple sclerosis.
    Eriksen AB; Berge T; Gustavsen MW; Leikfoss IS; Bos SD; Spurkland A; Harbo HF; Blomhoff HK
    J Neuroimmunol; 2015 Jan; 278():11-8. PubMed ID: 25595247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
    Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
    Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trans-omics analyses revealed key epigenetic genes associated with overall survival in secondary progressive multiple sclerosis.
    Ye F; Dai Y; Wang T; Liang J; Wu X; Lan K; Sheng W
    J Neuroimmunol; 2022 Mar; 364():577809. PubMed ID: 35026432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis.
    Ahmadian-Elmi M; Bidmeshki Pour A; Naghavian R; Ghaedi K; Tanhaei S; Izadi T; Nasr-Esfahani MH
    Immunogenetics; 2016 Jan; 68(1):43-54. PubMed ID: 26563334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients.
    Rhead B; Brorson IS; Berge T; Adams C; Quach H; Moen SM; Berg-Hansen P; Celius EG; Sangurdekar DP; Bronson PG; Lea RA; Burnard S; Maltby VE; Scott RJ; Lechner-Scott J; Harbo HF; Bos SD; Barcellos LF
    PLoS One; 2018; 13(10):e0206511. PubMed ID: 30379917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A DNA-Methylated Sight on Autoimmune Inflammation Network across RA, pSS, and SLE.
    Wang X; Lei D; Ding J; Liu S; Tao L; Zhang F; Peng J; Xu J
    J Immunol Res; 2018; 2018():4390789. PubMed ID: 30159339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sjögren's syndrome.
    Altorok N; Coit P; Hughes T; Koelsch KA; Stone DU; Rasmussen A; Radfar L; Scofield RH; Sivils KL; Farris AD; Sawalha AH
    Arthritis Rheumatol; 2014 Mar; 66(3):731-9. PubMed ID: 24574234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D receptor gene is epigenetically altered and transcriptionally up-regulated in multiple sclerosis.
    Ayuso T; Aznar P; Soriano L; Olaskoaga A; Roldán M; Otano M; Ajuria I; Soriano G; Lacruz F; Mendioroz M
    PLoS One; 2017; 12(3):e0174726. PubMed ID: 28355272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-blood methylation signatures are associated with and accurately classify multiple sclerosis disease severity.
    Campagna MP; Xavier A; Lea RA; Stankovich J; Maltby VE; Butzkueven H; Lechner-Scott J; Scott RJ; Jokubaitis VG
    Clin Epigenetics; 2022 Dec; 14(1):194. PubMed ID: 36585691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.